---
layout: single
title: "Curriculum Vitae"
permalink: /cv/
author_profile: true
---

# Meghna Verma, Ph.D.  
Associate Director, Systems Medicine | Clinical Pharmacology & Quantitative Pharmacometrics  
AstraZeneca, Gaithersburg, MD, USA  

ðŸ“§ [meghnaverma.phd@gmail.com](mailto:meghnaverma.phd@gmail.com)  
ðŸ“± +1-540-235-4986  
ðŸ”— [GitHub](https://github.com/meghna-verma) | [ORCID](https://orcid.org/0000-0002-7776-0433) | [LinkedIn](https://linkedin.com/in/YOUR-LINKEDIN)  

---

## ðŸ”¹ Summary
PhD with 5+ years of industry experience at AstraZeneca supporting **Model-Informed Drug Development (MIDD)**.  
Expertise in **QSP, PK/PD, viral dynamics, cytokine release, TCE models**, and regulatory submissions (EUA, IND).  

---

## ðŸ’¼ Professional Experience

### AstraZeneca â€” Associate Director, Systems Medicine  
*Jan 2020 â€“ Present*  
- Developed **QSP trimer-based TCE models** for autoimmune diseases, supporting IND filing of *AZD0486*.  
- Built **cytokine release models** to assess safety and dosing strategies.  
- Led **viral dynamics modeling** of SARS-CoV-2, contributing to EUA approval of *EVUSHELD*.  
- Drafted ICH-compliant **modeling reports** and regulatory responses (FDA, EMA, HC, Swissmedic).  
- Championed **modeling templates** for reproducibility and regulatory consistency.  

---

### Virginia Tech â€” Graduate Research Assistant  
*Aug 2015 â€“ Dec 2019*  
- Built **agent-based and ODE models** of immune responses (*C. difficile*, *H. pylori*).  
- Developed **HIV/HPV co-infection models** in MATLAB and COPASI.  
- Applied ML for **Crohnâ€™s disease in silico clinical trials**.  
- **Original website content (archived):**  
  > Developed a mechanistic ODE model of HIV/HPV coinfection and studied antiretroviral treatment effects.  
  > Designed hybrid frameworks integrating agent-based and differential equations for infectious disease simulations.  
  > Built AI surrogate models to accelerate QSP virtual population generation.  

---

### University of Virginia â€” Graduate Research Assistant  
*Feb 2015 â€“ Jun 2015*  
- Modeled influenza vaccination effectiveness in **urban vs rural US populations**.  

---

## ðŸŽ“ Education
- **Ph.D. Translational Biology, Medicine & Health (Computational Immunology)** â€” Virginia Tech, 2019  
- **M.S. Biomedical Engineering (Bioinformatics)** â€” Drexel University, 2014  
- **B.E. Biomedical Engineering** â€” Mumbai University, 2011  

---

## ðŸ›  Skills
- Modeling: QSP, PK/PD, viral dynamics, disease progression  
- Tools: MATLAB, R, Python, MONOLIX, Git  
- AI/Automation: ChatGPT, Gemini, Claude, GitHub Copilot  
- Regulatory Writing: IND, EUA, ICH M15  

---

## ðŸ† Awards & Recognition
- AZ CEO Award â€” COVID-19 modeling  
- AZ Global Head AI Award â€” Cytokine release modeling  
- EVUSHELD approval contributions â€” Biopharm R&D Award  
- Travel awards â€” ISCB, SBHD, SAMSI, VT GSA  

---

## ðŸ“š Selected Publications
- Volkova S, **Verma M**, et al. (2025). *IFN-mediated inflammation in SLE*. **CPT:PSP**  
- Beattie KA, **Verma M**, et al. (2024). *Quantitative systems toxicology modeling*. **CPT:PSP**  
- Lai C, **Verma M**, et al. (2024). *T-cell engager modeling*. **Front Pharmacol**  
- **Verma M**, Gall L, et al. (2023). *Case studies in QSP for MIDD*. **Front Syst Biol**  
- Full list on [ORCID](https://orcid.org/0000-0002-7776-0433)  

---

## ðŸ“„ Download CV
For a PDF version: [Download here](/files/Verma_CV.pdf)
